Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers.

Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers.

Item
http://www.wikidata.org/entity/Q38868396
Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis.LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial.STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.
P2860

Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers.

Item
http://www.wikidata.org/entity/Q38868396
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Checkpoint Inhibitors in Head ...... ity, and Potential Biomarkers.
@en
type
label
Checkpoint Inhibitors in Head ...... ity, and Potential Biomarkers.
@en
prefLabel
Checkpoint Inhibitors in Head ...... ity, and Potential Biomarkers.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Checkpoint Inhibitors in Head ...... ity, and Potential Biomarkers.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921